Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 5/20 | 0.33 |
| ▸ | CNR1 | P21554 | 4/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.33 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.33 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29908705 | 0.93 | FTO (0.54) | FTOCNR2CNR1TRPA1TRPV1 | |
| SCHEMBL4665594 | 0.93 | FTO (0.54) | FTOCNR2CNR1TRPA1TRPV1 | |
| SCHEMBL24124089 | 0.86 | FTO (0.50) | FTOCNR2CNR1TRPA1TRPV1 | |
| SCHEMBL7522231 | 0.84 | FTO (0.53) | FTOCNR2CNR1TRPA1TRPV1 | |
| SCHEMBL7520930 | 0.83 | FTO (0.52) | FTOAKR1B1CNR2CNR1TRPA1 | |
| SCHEMBL9008421 | 0.83 | FTO (0.52) | FTOAKR1B1CSNK2A1CNR2CNR1 | |
| SCHEMBL5042296 | 0.80 | FTO (0.40) | FTOAKR1B1LMNANPC1MAPT | |
| SCHEMBL12251392 | 0.79 | FTO (0.42) | FTOCNR2CNR1TRPA1TRPV1 | |
| SCHEMBL772979 | 0.77 | FTO (0.55) | FTOCNR2LMNAMAPTKMT2A | |
| SCHEMBL30717253 | 0.77 | FTO (0.55) | FTOCNR2LMNAMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7425320-B2 | Use of guaiol for treating the skin | CIBA SPECIALTY CHEMICALS CORP (US) | 2008-09-16 | — | — | US | disclosed |
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | CIBA SPECIALTY CHEMICALS CORP. | 2005-03-17 | — | — | US | disclosed |
| EP-1432400-A1 | USE OF GUAIOL FOR TREATING THE SKIN | Ciba SC Holding AG (CH) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003024417-A1 | USE OF GUAIOL FOR TREATING THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050058610-A1 | Cosmetic mixtures containing ultraviolet radiation absorber and decoloring agents | TYR, MC1R, UNG | FTO 1161/4885AKR1B1 1153/4885CSNK2A1 4513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.